BioCryst Pharmaceuticals | BCRX - Eps Gewinn Pro Aktie

Aktienkurs
9.38
Täglich Wechseln
-0.28 -2.90%
Monatlich
18.73%
Jährlich
20.26%
Q1 Prognose
9.41

Fiscal Kalender Aktuell Konsens Zuletzt Datum




Eps Veränderung Datum
Alnylam Pharmaceuticals USD 1.25 1.65 2025-12
BioCryst Pharmaceuticals USD 1.17 1.1 2025-12
Chugai Pharma JPY 78.03 10.45 2025-12
Daiichi Sankyo JPY 46.79 22.27 2025-12
DBV Technologies USD -0.24 1.31 2025-09
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
Gilead Sciences USD 1.86 0.61 2025-12
GlaxoSmithKline GBP 0.26 0.29 2025-12
Glaxosmithkline GBP 0.21 0.51 2025-12
Incyte USD 1.8 0.46 2025-12
Ionis Pharmaceuticals USD -1.41 0.61 2025-12
Karyopharm Therapeutics USD -0.15 0.11 2024-12
Neurocrine Biosciences USD 1.88 0.29 2025-12
Novavax USD 0.13 0.59 2025-12
PTC Therapeutics USD -1.67 1.87 2025-12
Regeneron Pharmaceuticals USD 11.44 0.39 2025-12
Roche Holding CHF 8.37 2.95 2025-12
Sarepta Therapeutics USD -3.58 3.45 2025-12
Ultragenyx Pharmaceutical USD -1.29 0.52 2025-12
Vertex Pharmaceuticals USD 5.03 0.23 2025-12